Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study

Figure 1

Relapse-free and overall survival by banded biomarker score in the test and validation sets. For each patient, scores for eight immunohistochemical biomarkers assessed were determined; each biomarker was scored as 1 if predicting poor prognosis in univariate analysis for that patient. Patients were then banded by scores of 0, 1 to 4, and 5 to 8. P values were obtained by log rank test.

Back to article page